R. Vos (Leuven, Belgium), C. Benden (Zürich, Switzerland)
Creatine supplementation attenuates inflammation in collateral lung after left lung transplantation
F. Almeida (Sao Paulo, Brazil), A. Battochio (Sao Paulo, Brazil), J. Napoli (Sao Paulo, Brazil), K. Alves (Sao Paulo, Brazil), G. Balbin (Sao Paulo, Brazil), M. Oliveira-Junior (Sao Paulo, Brazil), H. Moriya (Sao Paulo, Brazil), P. Pego-Fernandes (Sao Paulo, Brazil), R. Vieira (Sao Jose dos Campos, Brazil), R. Pazetti (Sao Paulo, Brazil)
|   |
Effects of tacrolimus on mechanical and humoral determinants of brain death-induced lung injury.
A. Belhaj (Yvoir, Belgium), L. Dewachter (Brussels, Belgium), K. Mc Entee (Brussels, Belgium), R. Naeije (Brussels, Belgium), B. Rondelet (Yvoir, Belgium)
| |
Integrated mRNA and miRNA expression profiling of long-term survivors with normal allograft function after lung transplantation
A. Mendoza-Valderrey (Barcelona, Spain), S. Gómez-Olles (Barcelona, Spain), R. Gonzalo (Barcelona, Spain), A. Sánchez-Pla (Barcelona, Spain), M. Hernández-Fuentes (London, United Kingdom), R. Escobar (Barcelona, Spain), C. Berastegui (Barcelona, Spain), B. Sáez (Barcelona, Spain), A. Solé (Valencia, Spain), F. Zurbano (Santander, Spain), M. De La Torre (A Coruña, Spain), R. Laporta (Madrid, Spain), J. Redel (Córdoba, Spain), A. Román (Barcelona, Spain)
| |
Immunophenotype and gene signature of long-term survivors with normal allograft function after lung transplantation
A. Mendoza-Valderrey (Barcelona, Spain), S. Gómez-Olles (Barcelona, Spain), A. Sánchez-Pla (Barcelona, Spain), R. Gonzalo (Barcelona, Spain), M. Hernández-Fuentes (London, United Kingdom), R. Escobar (Barcelona, Spain), C. Berastegui (Barcelona, Spain), B. Sáez (Barcelona, Spain), A. Solé (Valencia, Spain), F. Zurbano (Santander, Spain), M. De La Torre (A Coruña, Spain), R. Laporta (Madrid, Spain), J. Redel (Córdoba, Spain), A. Román (Barcelona, Spain)
| |
In vitro model to study the correlation between neutrophils and miR21 expression: a role in Bronchiolitis obliterans syndrome
L. Pandolfi (Pavia, Italy), V. Frangipane (Pavia, Italy), H. Recalde (Pavia, Italy), P. Morbini (Pavia, Italy), S. Bozzini (Pavia, Italy), E. Rossi (Pavia, Italy), F. Meloni (Pavia, Italy)
| |
M2 polarized macrophages in bronchoalveolar lavage of lung transplant recipients
F. Meloni (Pavi, Italy), L. Pandolfi (Pavi, Italy), V. Frangipane (Pavi, Italy), M. Morosini (Pavi, Italy), M. Cagnone (Pavi, Italy), M. D'Amato (Pavi, Italy), L. Saracino (Pavi, Italy), A. Bardoni (Pavi, Italy)
| |
Bile acid aspiration associated to early CLAD development and dysregulation of airway lipids
A. URSO (NEW YORK, United States of America), F. Briganti (NEW YORK, United States of America), R. Nandakumar (NEW YORK, United States of America), L. Benvenuto (NEW YORK, United States of America), J. Costa (NEW YORK, United States of America), H. Robbins (NEW YORK, United States of America), L. Shah (NEW YORK, United States of America), J. Sonett (NEW YORK, United States of America), S. Cremers (NEW YORK, United States of America), S. Arcasoy (NEW YORK, United States of America), F. D'Ovidio (NEW YORK, United States of America)
| |
Aspirated bile acids affect lung immunity and function
A. URSO (NEW YORK, United States of America), J. Perez-Zoghbi (NEW YORK, United States of America), R. Nandakumar (NEW YORK, United States of America), S. Cremers (NEW YORK, United States of America), N. Bunnett (NEW YORK, United States of America), C. Emala (NEW YORK, United States of America), F. D'Ovidio (NEW YORK, United States of America)
| |
Small airway dilation visualized by optical coherence tomography (OCT) correlates with the diagnosis of chronic lung allograft dysfunction (CLAD).
J. Malone (Vancouver, Canada), A. Lee (Vancouver, Canada), G. Hohert (Vancouver, Canada), P. Lane (Vancouver, Canada), R. Nador (Vancouver, Canada)
| |
Efficacy of imatinib loaded-antiCD44 coated gold nanoparticles: a possible new therapeutic approach to BOS
F. Meloni (Pavia, Italy), R. Di Paola (Messina, Italy), P. Morbini (Pavia, Italy), L. Pandolfi (Pavia, Italy), V. Frangipane (Pavia, Italy), E. Gugliandolo (Messina, Italy), E. Cova (Pavia, Italy), M. Colombo (Milano, Italy), D. Prosperi (Milano, Italy), P. Vitulo (Palermo, Italy), G. Ferrario (Pavia, Italy), R. Fusco (Pavia, Italy), C. Pacini (Milano, Italy), R. Siracusa (Milano, Italy), S. Cuzzocrea (Messina, Italy)
| |
Total Lymphoid Irradiation (TLI) for the Management of Bronchiolitis Obliterans Syndrome (BOS) Post Lung Transplant: A Single Centre Experience
E. Hunt (Dublin, Ireland), P. Ging (Dublin, Ireland), I. Lawrie (Dublin, Ireland), S. Winward (Dublin, Ireland), S. Towell (Dublin, Ireland), C. Gillham (Dublin, Ireland), J. Egan (Dublin, Ireland), M. Murray (Dublin, Ireland), J. Kleinerova (Dublin, Ireland)
| |
Potential risk factors for poor outcomes post-lung transplant for cystic fibrosis
C. Rutherford (Dublin, Ireland), S. Towell (Dublin, Ireland), I. Lawrie (Dublin, Ireland), S. Winward (Dublin, Ireland), P. Ging (Dublin, Ireland), J. Kleinerova (Dublin, Ireland), J. Egan (Dublin, Ireland), M. Murray (Dublin, Ireland)
| |
Survival benefit of lung transplantation for cystic fibrosis in Norway
S. Pathak (Oslo, Norway), M. Durheim (Oslo, Norway), P. Finstad (Oslo, Norway), A. Holm (Oslo, Norway), I. Leuckfeld (Oslo, Norway)
| |
Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers
M. Phillips Houlbracq (Suresnes, France), H. Mal (Paris, France), V. Cottin (Lyon, France), F. Philit (Lyon, France), S. Hirschi (Strasbourg, France), A. Roux (Suresnes, France), L. Wémeau-Stervinou (Lille, France), J. Le Pavec ( Le Plessis-Robinson, France), C. Pison (Grenoble, France), S. Marchand Adam (Tours, France), A. Froidure (Bruxelles, Belgium), R. Lazor (Lausanne, Switzerland), J. Naccache (Paris, France), S. Jouneau (Rennes, France), H. Nunes (Bobigny, France), M. Reynaud-Gaubert (Marseille, France), A. Le Borgne (Toulouse, France), B. Crestani (Paris, France), C. Kannengiesser (Paris, France), R. Borie (Paris, France)
| |
Impact of antifibrotic drugs in lung transplantation
J. Carrillo Hernández-Rubio (Majadahonda, Spain), S. Aguado Ibañez (Majadahonda, Spain), R. Laporta Hernández (Majadahonda, Spain), M. Ussetti Gil (Majadahonda, Spain)
| |
ISHLT Registry Data and Country Registries: Comparison of reported European Lung Transplant Activities in 2016
E. Hofstetter (Munich, Germany), N. Roth Henig (Munich, Germany), G. Boerner (Munich, Germany)
| |
Is oscillometry a better metric of respiratory functional capacity compared to conventional pulmonary function tests during the first 6-months post lung transplant?
E. DeHaas (Toronto, Canada), J. Wu (Toronto, Canada), E. Cho (Toronto, Canada), D. Birriel (Toronto, Canada), C. Ryan (Toronto, Canada), C. Chow (Toronto, Canada)
| |
Effect of high intensity training after lung transplantation
M. Ulvestad (Oslo, Norway), M. Durheim (Oslo, Norway), J. Kongerud (Oslo, Norway), M. Lund (Oslo, Norway), E. Edvardsen (Oslo, Norway)
| |